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ABSTRACT
Hepatitis C virus (HCV) infected 30,500 people in the United States alone in 2014. As a
positive-sense single-stranded RNA virus, the HCV genome facilitates translation and replication
of the virus within the host cell. During infection, HCV subverts numerous host proteins to aid in
viral production. One such protein is DDX6, a DEAD-box helicase that is associated with the
decapping complex and microRNA Induced Silencing Complex (miRISC). Previous studies in
our lab have shown that DDX6 is required for HCV expression. Specifically, DDX6 modulates
the interaction of miR-122 with the HCV 5’ UTR and promotes stability and replication of the
viral genome. To elucidate which enzymatic activities of DDX6 are required to promote HCV
gene expression, we used site-directed mutagenesis to disrupt the enzymatic activities of DDX6.
Specifically, we mutated the ATPase, RNA binding and helicase domains within 3x-FlagDDX6Δsi plasmid DNA. We next used lentivirus transduction to stably express the 3xFlagtagged DDX6 mutants in Huh7 cells, in which expression of endogenous DDX6 was deleted by
gene editing using CRISPR-Cas9. Analysis by immunofluorescence staining and confocal
microscopy of uninfected cells, shows wild-type 3xFlag-DDX6 localizing in processing bodies,
while the enzymatic mutants show diffuse cytoplasmic staining. DDX6 stable cell lines were
infected with the HCV infectious clone JFH-1, and at three-days post-infection cells were
harvested and viral and cellular protein and RNA abundance analyzed by western and northern
blotting, respectively. Surprisingly, only DDX6 knock-out cells expressing the wild-type
3xFlag-DDX6 were infected with HCV. These data show that the enzymatic activities of DDX6
are critical for HCV infection. Since RNA helicases unwind RNA, it is possible that the helicase
and RNA binding activities of RCK/p54 are necessary to remodel the complex secondary
structures found on the 5’ and 3’ untranslated regions of the HCV genome, and may play an
important role in the transition between translation and replication.
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INTRODUCTION
Hepatitis C virus (HCV) infects 71 million people globally. The virus is primarily spread
through contaminated blood. Approximately 25% of individuals will develop an acute infection.
Most patients however develop a chronic infection, and this chronic infection increases the
patient’s risk to develop serious liver problems such as cirrhosis of the liver and hepatocellular
carcinoma.1 The early HCV treatments used the dual treatment strategy with interferon- and
ribavirin. While effective, the interferon-/ribavirin treatment had limited success, as patients
frequently became nonresponsive and developed severe side effects.2 More recently direct-acting
antivirals (DAAs), targeting the HCV NS3/4A protease, NS5A phosphoprotein and NS5B RNAdependent RNA polymerase, have become available.2 Although these DAAs have significantly
improved treatment outcomes, the NS3/4A inhibitors in particular, show lower reactivity across
the HCV genotypes and resistance variants are common. 2 Therefore continuing research on
HCV may reveal additional effective anti-HCV therapies.

Molecular Biology of HCV
HCV is an enveloped, single-stranded, positive-sense RNA virus in the Flaviviridae
family of viruses.3 Other well known viruses in this family include Yellow Fever virus, West
Nile virus, Dengue virus and the recently re-emerging Zika virus. The viral RNA contains a
single open reading frame, and 5’ and 3’ untranslated regions (UTRs) (Figure 1). HCV uses the
viral genome as a template for translation and replication within the host cell. Translation of the
HCV genome is directed by the binding of a 40S ribosomal subunit directly to the internal
ribosomal entry site in the 5’ untranslated region which results in the production a polyprotein
that is cleaved into ten viral proteins. The three structural proteins (core, envelope E1 and E2)
5’ UTR

Open Reading Frame (ORF)

3’ UTR

Figure 1. Schematic of the HCV genome. The red box highlights the internal ribosomal entry site.
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and seven non-structural (p7, NS2-5B) (Figure 1), and facilitate viral RNA replication and
assembly into viral particles, and suppression of the innate immune response.3
The life cycle of HCV occurs entirely in the cytoplasm of the cell.4 The virus binds four
different receptor and enters the cell by fusing the viral envelope with the cellular endosomal
membrane. Viral proteins are immediately following release of the viral RNA into the
cytoplasm. The synthesis of the viral proteins such as the HCV NS3/4A protease, NS5A
phosphoprotein and NS5B RNA-dependent RNA polymerase facilitate replication of the HCV
genome. Replication of the HCV genome occurs using a negative-sense RNA intermediate. The
virus assembles on lipid droplets and buds into the ER. New viral particles are released from the
cell via the secretory pathway.4 At each step in the life cycle, HCV interacts with numerous host
cell proteins. My research investigate the role of one such host protein namely RCK/p54.

RCK/p54 (DDX6)
RCK/54 is a DEAD-box RNA helicase. The protein contains conserved sequences
associated with ATP binding and hydrolysis, helicase and RNA binding activity.5 The protein is
a key component of processing bodies, RNA-protein granules associated with mRNA storage
and degradation. RCK however also functions with other proteins to promote decapping of
mRNAs and microRNA-mediated gene regulation.5 Interestingly, RCK/p54 has also been shown
to be an oncogene,6 and is overexpressed in individuals living with chronic HCV infection.7
Many viruses use RCK, although the function of RCK during infection is largely unknown.5
Research from the Pager laboratory has previously shown that knockdown of RCK using targetspecific siRNAs decreases the levels of HCV protein and RNA.8 Interestingly this protein also
co-localized with core protein at lipid droplets suggesting a role in the assembly of new HCV
particles.8 More recently they have shown that RCK affects the stability and replication of the
HCV RNA, likely by directly the binding of the liver-specific microRNA miR-122 to a particular
site in the 5’ UTR.9 We hypothesize that the enzymatic activities of RCK are required to promote
HCV gene expression. Therefore, the rationale of this project was to express mutant RCK
proteins containing enzymatic deficiencies in Huh 7 cells and investigate which enzymatic
properties are important for the HCV life cycle. If any of the enzymatic activities are important
for HCV gene expression, we predict a decrease in the levels of viral core protein and viral RNA
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when analyzed by western blot and northern Blot analysis respectively, and a decrease in
luciferase units for analysis of viral translation and replication using a reporter genome.
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MATERIALS AND METHODS
Site-Directed Mutagenesis
Site-directed mutagenesis on the p3xFlag-RCKΔsi plasmid was performed using a Quick
Change Lightening Kit (Agilent) and mutagenesis primer with point mutations, as per the
manufacturer’s instructions. In brief, the following PCR reaction conditions were used: 1 cycle at
95°C for 2 minutes; 18 cycles at 95°C for 20 seconds, 60°C for 10 seconds and 68°C for 2
minute; and 1 cycle at 68°C for 5 minutes. Table 1 shows the point-mutations introduced into
p3xFlag-RCKΔsi. Following the PCR reaction, the DNA wasincubated with 2 µl of Dpn1 and
transformed into XL10 gold E. coli with 1 µl of -mercaptoethanol for 30 minutes on ice. The
bacteria was heat shocked at 42°C for 30 seconds and then incubated on ice for 2 minutes. SOC
media was added after the transformation reaction, and the reaction was shaken at 37°C for one
hour. The bacteria hereafter were spread onto an agar plate containing LB agar and carbenicillin
(Sigma) and incubated overnight at 37°C. Two bacterial colonies were picked and grown at 225
rpm in a 5ml LB solution containing 0.1 mg/ml ampicillin (Sigma) overnight at 37°C. A
miniprep was performed using EZNA plasmid DNA mini kit (OMEGA Bio-Tech). The plasmids
were submitted for sequenceanalysis to confirm presence of the mutations. The confirmed
plasmids were re-transformed into DH5 bacteria, grown overnight on LB agar and carbenicillin
plates at 37°C. Single-colonies were picked to start 100ml LB/ampicillin solution. The bacteria
were grown overnight at 37°C at 225rpm. Hereafter, the plasmid was isolated using an EZNA
plasmid DNA maxi kit (OMEGA Bio-Tech).

Huh7 and RCK/p54 Huh7 Knockout (KO) Cells
Huh7 cells are a human hepatoma cell line. In our studies we also used RCK/p54
knockout Huh7 cells.10 These were generated through CRISPR/Cas9 gene editing and were a
kind gift from Dr. Jan Carette (Department of Microbiology and Immunology, Stanford
University). The cells were maintained at 37°C with 5% CO2 in DMEM (Life Technologies), 1
mM non-essential amino acids (Life Technologies), 10% fetal bovine serum (FBS; Seradigm)
and 1% L-glutamine (Life Technologies). To passage cells, the media was removed and cells
were washed two times in 3ml phosphate buffered saline (PS; Life Technologies). Hereafter the
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cells were incubated in 1ml trypsin/EDTA solution (Life Technologies) for 5 minutes at 37°C.
The trypsin/EDTA solution was inactivated with normal media and cells replated into 100 mm
tissue culture plates at 1:3-1:5 ratio. For siRNA and plasmid transfection experiments, Huh7
cells were seeded into 60 mm tissue culture plates at 8x105 cells per plate 4 hours prior to
transfection.

Plasmids and siRNAs
The control plasmid used in this study were the p3xFlag-Bacterial Alkaline Phosphate
(BAP) (Sigma) and p3xFlag-RCKΔsi wild type (WT). Reference 9 describes the cloning of RCK
WT into the p3xFlag plasmid, as well as the site-directed mutagenesis PCR perform to mutate
the RCK siRNA binding site (Δsi), such that expression of 3xFlag-RCKΔsi would not be
affected by the siRNA gene silencing mechanism.9 The particular mutations to the RCK
enzymatic activities are as follows: 1) a mutation within the DEAD-box motif (E247Q,
DEAD>DQAD) to affect ATPase activity; and 2) two different mutations in motif III
(S277A/T279A, SAT>AAA) and motif Va (G397A; RGID>RAID) to affect helicase activity. 3)
Two additional mutations were created to affect RNA binding R174A/R225A and
R174E/R225E. In the first mutant, the arginines are mutated to neutral amino acids (alanine),
while in the second mutant the arginines are mutated to negatively-charged amino acids
(glutamic acid). Table 1 shows the point-mutations introduced into p3xFlag-RCKΔsi. The small
interfering RNAs (siRNAs) used were siGL2 and siRCK/p54: 1) siGL2 (5’CGUACGCGGAAUACUUCGAUU-3’) was used as a negative contro siRNA. This siRNA
targets Gaussian Luciferase 2 (GL2) mRNA, a gene not expressed in Huh7 cells. siGL2 does not
affect RCK nor HCV gene expression. 2) siRCK (5’-GCAGAAACCCUAUGAGAUUUU-3’)
silences endogenous RCK mRNA expression.

Lipofectamine Transfection
Transfection of Huh7 and RCK KO cells were performed using Lipofectamine 2000
(Invitrogen). For one transfection reaction, a master mix containing 0.5 ml of OptiMEM was
added to a 14 ml tube with 10 µl of Lipofectamine 2000. The second master mix containing the
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siRNA and plasmid was prepared in a separate 14 ml tube. To this tube 500 µl of OptiMEM was
added together with 5 µl of 20 µM siRNA (final concentration of 100 nM) and 1 g plasmid
DNA. After a five-minute incubation period, 500 µl of the Lipofectamine 2000 solution was
added to the tubes containing the siRNA and plasmid. The mixtures were further incubated for
20 minutes at room temperature. While this mixture was incubating, the media in the Huh7
plates was aspirated off, and cells were washed with 1 ml of PBS to remove any excess media.
Then each separate transfection mix was added at 1 ml to each plate. The plates incubated for 4
hours at 37°C. Hereafter 3 ml of media was added to the cells, and the cells were further
incubated overnight at 37°C.

HCV Infection of Huh 7 cells
Twenty-four hours after transfection the Huh 7 cells were infected with the HCV
infectious clone JFH-1 (a kind gift from Dr. Takaji Wakita, Tokyo Metropolitan Institute of
Neuroscience) at a multiplicity of infection (MOI) of 0.1. Six hours after infection, the cells were
trypsinized and re-plated into a 100 mm tissue culture plate. To analyze HCV gene expression,
cells were harvested 48 hours post-infection (p.i.). Specifically, the media from the infected cells
was aspirated and the cells were washed in approximately 2 ml of PBS. This wash was then
aspirated and 1 ml of PBS was added to each plate. The cells were then dislodged using a cell
lifter. The suspended cells were either divided into two tubes for protein and RNA analysis,
respectively, or processed further for protein analysis. The cells in PBS were centrifuged for 10
seconds at 10,000 rpm. The PBS was aspirated and the cell pellet that was re-suspended in 100
µl of RIPA buffer (100 mM Tris-HCl (pH 7.4), 1% sodium deoxycholic acid, 1% Triton-X100,
0.1% SDS, 150 mM NaCl, and containing the EDTA-free Complete protease inhibitors cocktail
(Thermo Fisher Scientific), or 1 ml TRIzol (Life Technologies). Protein lysates were further
processed by incubation on ice for 20 minutes, and centrifugation at 14,000 rpm at 4°C for 20
minutes to pellet the cellular debris. The supernatant layer containing the solubilized protein
lysate was placed in a separate tube to be used for western blot analysis.
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BCA Quantification
To measure the concentration of protein in the cell lysates, a 1:5 dilution of the protein
lysate in PBS. The standard BSA concentrations at 200 ng/µl, 400 ng/µl, 600 ng/µl, 800 ng/µl
and 900 ng/µl were prepared. A volume of 1.13 µl of reagent A was added to 22.6 µl of reagent
S to create an “A” solution. First, 25 µl of this solution was added to each well as well as 5 µl of
each standard and sample. To create a color change, 200 µl of reagent B was then added. The
absorbance at 562 nm from the BCA protein quantification assay (BioRad) was analyzed using a
spectrophotometer (BioTek). The standard samples of BSA used to construct a standard curve
which was then used to calculate the concentrations of protein in the cell lysate.

SDS-Polyacrylamide Gel Electrophoresis (PAGE) and Western Blot Analysis
Using BCA results, 20 g cell lysate was prepared in RIPA buffer to a final volume of 20
l, and 5 µl of 5x SDS-PAGE loading buffer. The proteins were then denatured at 95°C for 5
minutes. The samples (25 µl) were loaded into a 10% SDS-PAGE and electrophoresed at 100 V
for two hours in 1x SDS-PAGE running buffer. The electrophoresed proteins were transferred
onto a PVDF membrane (that was activated in methanol) at 100 V for one hour at 4°C. After
transfer, the membrane was reactivated in methanol, and hydrated in dH2O and 1x PBS. To
examine consistency of protein loading, the membrane was stained in Ponceau S (Sigma). The
membrane was then placed in 5% skim “milk” powder in 1x PBS-Tween 20 (PBS-T) for an hour
at room temperature to block non-specific binding of antibodies to the membrane. The
membrane was incubated at 4°C overnight in primary antibody in 4 ml of 5% milk in PBS-T.
The following day, the blot was then washed in PBS-T 3 times for 10 minutes at room
temperature before incubation in the secondary antibody. The blot was incubated at room
temperature for one hour in secondary antibody before it was washed again three times with
PBS-Tween for 10 minutes. The blot was then imaged using a 1:1 mixture of Clarity ECL
reagent (BioRad) and H2O2. The following primary and secondary antibodies were used: rabbit
anti-DDX6 (RCK/p54) (1:5,000; Bethyl Laboratories A300-460A), mouse anti-GAPDH
(Calbiochem); and mouse anti-HCV Core C7-50 (1:1,000; Abcam ab2740), and HRP-conjugated
donkey anti-mouse and donkey anti-rabbit secondary antibodies (1:10,000; Santa Cruz
Biotechnologies).
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Clone 3xFlag Genes into pLenti6/V5-D™-TOPO® Vector
3xFlag-BAP and RCK/p54 WT and mutant genes in the p3xFlag plasmid were PCR amplified
using prCTP256 (5’-CACCATGGACTACAAAGACCATGAC-3’) and prCTP169 (5’TTATTAAGGTTTCTCATCTTCTACAGG-3’). The following PCR reaction was performed
using the high-fidelity Phusion DNA polymerase (Invitrogen): 1 cycle at 98°C for 30 seconds; 35
cycles at 98°C for 10 seconds, 55°C for 30 seconds and 72°C for 1 minute 30 seconds; and 1 cycle at
72°C for 10 minutes. The PCR products were cleaned-up using the QIAquick PCR purification kit

(QIAGEN) and eluted in 30 l distilled H2O. The PCR product was the incubated with
pLenti6/V5-D™-TOPO® vector (ThermoFisher) and a salt solution. The cloning reaction was
incubated at room temperature for 30 minutes. The cloned product (2 µl) was then added to 50
µl Stbl3 bacteria (ThermoFisher) and mixed gently. The vial was incubated on ice for 30 minutes
before heat shocked for 30 seconds at 42°C. After 2 minutes of incubating on ice the cells were
transferred to a 30 ml tube and 1 ml of SOC was added. The tube was shaken at 37°C for an hour
before 0.5 ml of the transformation product was plated onto LB agar and carbenicillin and
incubated at 37°C overnight. As above single colonies were picked for miniprep extraction and
sequence analysis. The plasmids were re-transformed into Stbl3 bacteria. Colonies were picked
and shaken with 20 ml LB broth at 37°C overnight. The lentivirus vectors were isolated using a
midiprep DNA kit (OMEGA Bio-Tech). The following lentivirus plasmids were used: ATPase
mutation (pLenti3xFlag-RCK-DEAD>DQAD), a Δ prion-related domain (PRD)
(pLenti3xFLAG-RCK∆PRD), and the helicase mutants (pLenti3xFlag-RCK SAT>AAA and
pLenti3xFlag-RCK-RGID>RAID).

Production of Lentivirus and Trnsduction of RCK KO Cells
To produce lentiviruses, 0.75 g pLenti6/V5-BAP and -RCK plasmids were transfected
into 293FT cells with 2.25 g ViraPower Lentiviral packaging mix using Lipofectamine 3000
(Invitrogen) according to the manufacturer’s instuctions. Media from transfected cells was
collected 24 hours post-transfection. This media containing lentivirus was stored at 4°C. Fresh
media was added to the cells, and again collected at 48 hours post-transfection. Media containing
lentivirus was filtered through a 0.45 m filter. To create RCK stable Huh7 cells, polybrene
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(Sigma) was added to the filtered lentivirus, and then added to the RCK KO cells. The RCK KO
cells were seeded in 60 mm tissue culture plates 24 hours prior transduction. The media
containing lentivirus and polybrene (6 g/ml; Sigma) were incubated on the KO cells for 24
hours. Hereafter, the media was removed and replaced with fresh media. The cells were further
incubated for an additional 24 hours. Forty-eight hours post-transduction, KO cells transduced
with 3xFlag-BAP and -RCK were trypsinized and re-plated into 100 mm plates. Cells that were
stably transduced were placed under blasticidin selection (5 µg/µl; Invitrogen). These RCK
stable Huh7 cells were further maintained in blasticidin.

Northern Blot Analysis
RNA was extracted with TRIzol (Invitrogen) per the manufacturer’s instruction . Total
RNA (10 ug) was resuspended in loading buffer (1% MOPS-EDTA-sodium acetate (MESA),
67% formaldehyde, and 50% formamide). The RNA was denatured at 65°C for 10 minutes and
then separated in 1% formaldehyde/agarose gels and ran at 100 V. The RNA was transferred
onto a ZetaProbe membrane (BioRad) overnight and then crosslinked using Stratalinker. The
membrane was hybridized to examine actin and HCV using ExpressHyb hybridization buffer
(Clontech) and dATP-RadPrime DNA labeled (Invitrogen) probes [32P].8,9

Luciferase Assay
The subgenomic HCV reporter plasmids sgJFH-1 RLuc replication-competent (WT) and
replication-incompetent (GND) were a kind gift from Dr. Glan Randall (University of
Chicago).11 The plasmids were linearized with XbaI, and the linear DNA used as a template for
T7 Megascript in vitro transcription (Ambion) according to the manufacturer’s instructions.9
RCK KO cells stably expressing 3xFlag-BAP, and RCK WT and mutant genes were seeded into
24 well plates at 5x104 cells/well and incubated overnight at 37°C. Cells were transfected with
500 ng sgJFH-1 RLuc RNA using Lipofectamine MessengerMAX transfection reagent
(Invitrogen) according to the manufacturer’s instructions. Cells were lysed in 1x passive lysis
buffer (Promega) 6 hours and 48 hours post-transfection. Three replicates were measured in 96well plates using the Renilla reagent (Promega) in a luminometer (BioTek). This experiment was
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repeated once for replicability.
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RESULTS
Knockdown and rescue with wild-type and mutant RCK/p54 protein in Huh7 cells.
The first step in my study was to created mutations in the ATPase and helicase domains of RCK
cloned into a 3xFlag-plasmid (Table 1). To investigate the role of the enzymatic activities of
Enzymatic
Activity

Domain

aa position

WT Motif

Mutant
Motif

RCK during HCV
infection, we

ATPase

II

E247Q

DEAD

DQAD

transfected cells

Helicase

III

S277A/T279A

SAT

AAA

with a control

Helicase

Va

G397A

RGID

RAID

siRNA(siGL2) and

RNA Binding

Ia-Ic

R174A/R225A

TRE/GRI

TAE/GAI

a RCK target-

RNA Binding

Ia-Ic

R174E/R225E

TRE/GRI

TEE/GEI

specific siRNA,

such that endogenous RCK expressed in the cells would be depleted. To investigate the specific
Table 1. Mutations to disrupt RCK enzymatic activity.

effects of mutant RCK we co-transfected cells with a control plasmid (p3xFlag-BAP), and
p3xFlag-RCK WT and mutants. The p3xFLag-RCK plasmid had been further mutated such that
the mRNA expressed from the plasmid would be resistant to siRNA cleavage. Transfected cells
were then infected with JFH-1, the HCV infectious clone, and HCV protein abundance examined
3 days p.i. by western blot analysis. Lane

+ HCV

1 in Figure 2 shows uninfected Huh7
RGID>RAID

SAT>AAA

DEAD>DAAD

RCK WT

BAP

BAP + siGL2

Uninfected

+ siRCK/p54

cells. As expected no HCV core protein
was detected, and RCK and GAPDH are
expressed. Lanes 2-7 show protein from
:p3xFlag

HCV-infected cells. Co-transfection of
HCV Core

siGL2 and p3xFlag-BAP had no effect on

1

2

3

4

5

6

RCK/p54

RCK levels, and HCV core protein is

GAPDH

visible (lane 2). In contrast, cells

7

Figure 2. Expression of RCK wild type and
mutated RCK/p54 proteins during HCV infection.
Huh7 cells were co-transfected with siRNAs and
p3xFlag plasmids, and infected with HCV. Protein
abundance was analyzed by western blot analysis 3
days p.i.

transfected with siRCK and 3x Flag-BAP
plasmid resulted in significantly less RCK
protein and a decrease in HCV core
protein (lane 3). As expected, the
depletion of RCK and rescue with
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RCKsi WT (lane 4) shows a return to similar viral core level as the siGL2 and BAP plasmid
transfection in lane 2. Of note, the overexpressed 3xFlag- RCKsi WT and mutant proteins are
visible using the rabbit anti-RCK antibody. Because of the additional three Flag epitopes at the
N-terminus of RCK, these proteins migrate slower in the gel and are visible as the band above
the endogenous RCK band. The rescue with wild type RCK resulted in a double band of RCK.
Interestingly expression of the mutated RCK proteins deficient in ATPase and helicase activities
resulted in significantly less HCV core expression (lanes 5-7). The GAPDH levels, used as a
loading control, were even across all lanes. These data suggest that HCV gene expression
requires RCK ATPase and helicase activities.
+ HCV

The initial analysis of RCK enzymatic
TRE/GRI>TEE/GEI

TRE/GRI>TAE/GAI

RGID>RAID

SAT>AAA

DEAD>DAAD

RCK WT

BAP

BAP + siGL2

Uninfected

+ siRCK/p54

activities included the ATPase and
helicase motifs, but not the RNA binding
motif. We therefore created two additional
mutants in motif Ia and Ic. These motifs
:p3xFlag

are predicted to bind RNA and in the RNA

HCV Core

structure are opporiste from each other. In
RCK/p54
GAPDH
1

2

3

4

5

6

7

8

9

Figure 3. Expression of RCK wild type and
RCK/p54 mutant proteins deficient in ATPase,
helicase and RNA binding activities during HCV
infection. Huh7 cells were co-transfected with
siRNAs and p3xFlag plasmids, and infected with
HCV. Protein abundance was analyzed by western
blot analysis 3 days p.i.

RNA binding motifs, arginine (R) is a
common amino acids, as the positive
charge from the amino acid facilitates the
binding to the negatively-charged
phosphate backbone of RNA. We
therefore created two mutations, the first
mutating the arginines to the neutral amino
acid alanine (R174A/R225A) and also to

the negatively-charged glutamic acid (R174E/R225E). We predict both mutations would disrupt
RNA binding. Figure 3 shows similar results as Figure 2 on HCV core expression for the
control and RCK mutant proteins. The effect of the two mutant RNA-binding RCK proteins on
HCV core levels are shown in lanes 8 and 9. Changing the arginine in motifs Ia and Ic to an
alanine, decreased levels of HCV core protein. Unexpectedly, the point mutation from arginine
to glutamic acid in lane 9, showed similar HCV core expression as the WT rescue. While motifs
Ia and Ic are predicted to bind RNA, to our knowledge no biochemical assays have been
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undertaken to demonstrate this activity. Therefore, the RCK R174A/R225A mutant shows an
affect on HCV, however additional experiments should be performed before concluding that this
effect is due to disruption of RNA binding. Performing an immunoprecipitation of RCK WT and
R174A/R225A and examining RNA binding would be a first step to investigating this. This
assay would also provide insight into why R174E/R225E had no effect on HCV core expression.

Knockdown and rescue with wild-type and mutant

DEAD>DAAD

RCK/p54 protein in RCK knockout (KO) cells.
SAT>AAA

TRE/GRI>TAE/GAI

BAP

+HCV / RCK KO
RCK WT

+HCV / Huh7 WT

Mock / RCK KO

Mock / Huh7 WT

+ HCV

Because of variable knockdown efficiencies using
siRNAs, these experiments were repeated in Huh7
:p3xFlag
HCV Core
RCK/p54

cells in which CRISPR-Cas9 gene editing
technology had been used to knockout RCK.10 In
Figure 4, lanes 1 and 3 protein lysates from Huh7
WT cells. In these lanes endogenous RCK is

Flag M2
GAPDH
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5
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Figure 4. Transient expression of 3xFlag
WT and mutant proteins does not rescue
HCV gene expression. Huh7 cells and
Huh7 RCK KO were transfected with
p3xFlag plasmids, and then mock-infected
or infected with HCV. Protein abundance
was analyzed by western blot analysis 3
days p.i.

detected by western blot analysis. In contrast, but as
expected, no endogenous RCK is visible in the
RCK KO cells (Lanes 2 and 4). When HCV
infection was examined in Huh7 WT and RCK KO
cells, core protein was only detected in Huh7 WT
cells (lane 3). These data show that RCK is indeed
required for HCV gene expression.

We next examined HCV gene expression in RCK KO cells transiently expressing 3xFlag-BAP,
RCK WT and three enzymatic mutants of RCK (lanes 5-9). While immunoblotting for Flag
revealed transient expression of the 3xFlag proteins, these proteins were not detected using the
anti-RCK antibody (Figure 4). Moreover, HCV core protein was not detected (lanes 5-9), not
even when RCK WT expression was rescued in the RCK KO cells (lane 5). These data indicate
that transient expression of 3xFlag proteins is unable to rescue HCV gene expression.
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HCV gene expression in RCK KO stably expression 3xFlag BAP and RCK proteins.
Because transient expression of RCK WT and mutant proteins did not rescue HCV
gene expression we next sought to stably express these proteins in the RCK KO cells.
To this end we sub-cloned the 3xFlag-BAP, RCK WT and RCK mutant genes into the
pLenti vector. Lentiviruses expressing the genes were produced in 293FT cells, and
subsequently transduced into the RCK KO. Stable gene expression was achieved by
blasticidin selection.
SAT>AAA

RGID>RAID

DPRD

BAP

RCK WT

+ HCV

Using these stable cells expressing RCK WT and mutant
:3xFlag

proteins we next invested the effect on HCV gene

RCK/p54

expression. Specifically, the cells were infected with HCV

Flag M2

and cell lysates harvested 3 days p.i. We first investigated
protein expression by western blot analysis. We detected

GAPDH

RCK expression in cells stably expressing RCK WT,
1

2

3

4

5

RGID>RAID and SAT>AAA proteins (Figure 5, lanes 1,
Figure 5. HCV gene expression in
RCK KO cells stably expressing
3xFlag proteins. Huh7 RCK KO
stably expressing 3xFlag proteins
were infected with HCV , and
protein abundance was analyzed
by western blot analysis 3 days p.i.
Note: The data presented in this
figure are from the same blot. The
image however was rearranged for
this figure presentation.

and 4-5). We did not detect RCK expression in cells stably
expressing a mutant RCK protein in which the prionrelated domain (PRD) had been deleted (lane 3). The antiRCK antibody used in our studies targets the N-terminus
and with the deletion of the PRD domain, the antibody
recognition site was also deleted. However, the PRD
RCK protein was detected using the anti-Flag antibody

(lane 3). Disappointingly, we did not detect HCV protein.
Because we were unable to detect HCV core protein in Figure 5, we next investigated HCV
RNA abundance. RNA from the same experiment was extracted and analyzed by northern blot
(Figure 6). Northern blot analysis confirmed low levels of HCV RNA expression in BAP,
DDX6-E247Q and DDX6-SAT-AAA stable cell lines. HCV RNA was observed in KO cells
expressing RCK WT and RCK∆PRD (lanes 1 and 5). Consistent with our earlier data we did not
detect HCV RNA in cells stably expressing 3xFlag-BAP, or RCK DEAD>DAAD and
SAT>AAA (lanes 2-4). Figure 5 and Figure 6 together show that HCV can infect RCK KO
cells stably expressing RCK WT and RCK∆PRD, but not the mutant RCK proteins. Moreover,

the HCV infection in these cells is not as robust as in Huh7
cells.
DPRD

SAT>AAA

DEAD>DAAD

BAP

RCK WT
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HCV translation and replication in RCK KO stably
HCV RNA
Actin mRNA

1

2

3

4

5

Figure 5. HCV RNA abundance in
RCK KO cells stably expressing
3xFlag proteins. Huh7 RCK KO
stably expressing 3xFlag proteins
were infected with HCV, and RNA
abundance was analyzed by
norther blot analysis 3 days p.i.
Note: The data presented in this
figure are from the same blot. The
image however was rearranged for
this figure presentation.
Note: These data are from Gaston
Bonenfant, and used in this Thesis
with permission.

expression 3xFlag BAP and RCK proteins.
To determine if RCK affects HCV translation or
replication we used a subgenomic JFH-1 genome assay
containing the Renilla luciferase.11 This reporter genome
contains the HCV 5’ UTR followed by the Renilla
luciferase gene (RLuc). The RLuc is separated from the
HCV nonstructural proteins by an EMCV IRES. The 3’
UTR flanks the ORF containing the HCV NS2-NS5B
proteins. The sgJFH-1 genome was in vitro transcribed and
transfected into the RCK KO cells stably expressing
3xFlag proteins. Because the HCV genome is singl-

stranded positive-sense, the RNA is translated at early time points post-transfection (e.g. 6
hours). However over time and the accumulation of the HCV nonstructural proteins necessary
for replication, replication the sgJFH-1 genome, and with the increase in HCV genomes
luciferase activity at 48 hours post-transfection may be used as a proxy for replication. We
therefore measured luciferase expression 6 and 48 hours post-transfection (Figure 6), while the
luciferase measurement 48h post transfection served as a proxy for replication. For the RCK WT
we observed modest luciferase activity at 6
hours, which increased at 48 hours. In contrast
we observed low luciferase activity in cells
stably expressing the RCK the helicase mutant
(SAT>AAA).While these data are consistent
with earlier data we did observed modest
Figure 6. HCV translation and replication in
RCK KO cells stably expressing 3xFlag
proteins. Huh7 RCK KO stably expressing
3xFlag proteins were transfected with in vitro
transcribed sgJFH-1 RLuc RNA, and
harvested and Renilla luminescence measured
at 6 and 48 hours post-transfection.

luciferase activity at 48 hours post-infection,
suggesting that the helicase activity of RCK
may be important for HCV translation. For the
RCK ∆PRD mutant we observed luciferase
activity similar to RCK WT at 6 hours post-
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transfection. However, at 48 hours RCK ∆PRD dramatically increased luciferase data,
suggesting that PRD may limit HCV.
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DISCUSSION
The goal of this project was to investigate the role of RCK/p54 enzymatic activities on HCV
infection. To this end, 3xFlag-tagged RCK/p54 plasmids containing mutations in the enzymatic
domains (e.g. sites involved in ATPase, helicase, and RNA binding) were expressed in Huh7
cells depleted of endogenous RCK/p54 and infected with HCV. The results shown in Figure 2
and Figure 3 demonstrate successful knockdown of endogenous RCK and a corresponding
decrease in expression of HCV core following expression of the mutant RCK proteins. The
reduction of HCV core protein following expression of RCK/p54 containing mutations inhibiting
helicase (SAT>AAA; RGID>RAID), and ATPase (DEAD>DQAD) activities suggest these
enzymatic activities are critical for the function of RCK/p54 in promoting HCV gene expression.

RCK is a DEAD-box RNA helicases. Other proteins in this family have been shown to unwind
RNA, or RNA-protein interactions. Because ablation of the ATPase and helicase activities
affected HCV gene expression it is possible that these activities of RCK/p54 are necessary to
remodel the complex secondary structures found on the 5’ and 3’ untranslated regions of the
HCV genome, and/or remodel RNA-proteins to promote the transition between translation and
replication.

Mutating the putative RNA binding domain (R174/225A) also decreases of HCV core levels.
Unexpectedly, the R174/225E mutant did not have the same effect on HCV core protein. This
difference in RNA binding phenotypes may be a consequence of a possible conformation change
in the RCK protein or alternate mechanism to bind HCV RNA. While motifs Ia and Ic are
putative RNA binding domains, it is possible that these regions do not bind RNA, and rather
have a completely different function.

The observed decrease in HCV expression suggests that each of these mutations interfere with
the HCV infection. We verified these results in Huh7 cells lacking RCK. However, we did not
observe rescue of HCV gene expression when RCK was transiently expression, likely due to
inefficient transfection. To address this, we created RCK KO cells that stably express the 3xFlag-
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tagged proteins. In cells stably expressing RCK WT and ∆PRD we were able to detect HCV
RNA but not HCV core protein. However, using a sgJFH-1 RLuc reporter genome we
determined that the helicase mutant SAT>AAA likely affects translation, while the ∆PRD
promotes replication. Together this data indicates that HCV might subvert RCK to facilitate viral
gene expression at different steps in the infectious cycle.
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